Results 211 to 220 of about 173,135 (267)
Some of the next articles are maybe not open access.

Modified fluorometric quantitation of pancuronium bromide and metabolites in human maternal and umbilical serums.

Journal of Pharmacy and Science, 1979
The procedure for pancuronium bromid ion-pair extraction into chloroform using rose bengal and subsequent fluorometric measurement was modified by changing the extraction pH and eliminating phenol, ethanol, and acetone to give easier operation and ...
L. B. Wingard   +3 more
semanticscholar   +1 more source

Mechanism of selective cardiac vagolytic action of pancuronium bromide. Specific blockade of cardiac muscarinic receptors.

European Journal of Pharmacology, 1970
The selective vagolytic action of the potent steroidal neuromuscular blocker, pancuronium on the heart was analysed in cats, dogs and in isolated tissues of guinea-pigs.
Pramond R. Saxena, I. Bonta
semanticscholar   +1 more source

Pharmacological interaction between pancuronium bromide and anaesthetics

European Journal of Pharmacology, 1968
Abstract The interaction between the steroidal neuromuscular blocking agent pancuronium bromide and two anaesthetic agents was investigated in cats. Thiopentone or halothane reduced the effective neuromuscular blocking dose of pancuronium bromide. Under the influence of these the block anaesthetics induced by pancuronium bromide remained reversible ...
F. H. Derkx, I.L. Bonta, E.M. Goorissen
openaire   +4 more sources

A suicide by pancuronium bromide injection: evaluation of the fluorometric determination of pancuronium in postmortem blood, serum and urine.

Journal of Analytical Toxicology, 1980
A fatal case of suicidal injection of pancuronium bromide is presented. Pancuronium was detected in blood and urine by ion-pair extraction and fluorometry.
A. Poklis, E. Melanson
semanticscholar   +1 more source

Cardiovascular and neuromuscular effects of pancuronium bromide in the pony.

American Journal of Veterinary Research, 1983
Dosage level requirements of pancuronium bromide, a nondepoiarizing muscle relaxant, were studied in ponies. Cardiovascular and neuromuscular responses, duration of responses, and undesirable effects such as prolonged paralysis or residual weakness in ...
S. Manley   +3 more
semanticscholar   +1 more source

Hyperbilirubinemia following Exposure to Pancuronium Bromide in Newborns

Developmental Pharmacology and Therapeutics, 1990
We investigated the risk of hyperbilirubinemia in relation to the administration of pancuronium bromide among newborn infants requiring mechanical ventilation. One hundred and twenty-nine infants treated with pancuronium were compared to 129 infants who were never exposed, matched on ventilatory status, hospital, birthweight, initial total serum ...
Jonathan Freeman   +4 more
openaire   +3 more sources

Pancuronium Bromide

ASHP® Injectable Drug Information™, 2021

semanticscholar   +1 more source

Intravascular pancuronium bromide infusion for prenatal diagnosis of twin-twin transfusion syndrome.

Fetal Diagnosis and Therapy, 1992
The diagnosis of twin-twin transfusion syndrome remains a problem. Intravascular infusion of pancuronium bromide, a nondepolarizing neuromuscular blocking agent, for the smaller of a set of twins demonstrated paralysis of both twins in one case. However,
M. Tanaka   +5 more
semanticscholar   +1 more source

The use of intravenous pancuronium bromide to produce fetal paralysis during intravascular transfusion.

American Journal of Obstetrics and Gynecology, 1988
Intravascular fetal transfusion can be complicated by difficulty in maintaining vascular access because of fetal movements. Treatment by intramuscular pancuronium bromide has been proposed as a means of arresting fetal movements, although this treatment ...
J. Copel   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy